Valley News

For some patients seeking drugs like Ozempic, the best path is to just get sicker

A new Medicare pilot program launched on July 1 provides eligible Vermonters with access to weight-loss GLP-1 medications for a monthly cost of $50 through the end of 2027.

Read the original at Valley News

More audio from Valley News